Ignite Creation Date:
2024-05-06 @ 7:48 PM
Last Modification Date:
2024-10-26 @ 3:14 PM
Study NCT ID:
NCT06148220
Status:
RECRUITING
Last Update Posted:
2024-02-16
First Post:
2023-11-19
Brief Title:
A Study of the Clinical Application of 18FRCCB6 and 68GaGa-NOTA-RCCB6 PETCT Imaging in the Diagnosis of CD70-expressing Multiple Tumors
Sponsor:
Huashan Hospital
Organization:
Huashan Hospital
Study Overview
Official Title:
A Study of the Clinical Application of 18FRCCB6 and 68GaGa-NOTA-RCCB6 PETCT Imaging in the Diagnosis of CD70-expressing Multiple Tumors
Status:
RECRUITING
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of this study was to establish and optimize the 18FRCCB6 and 68GaGa-NOTA-RCCB6 PETCT imaging method and its physiological and pathological distribution characteristics on the basis of which the diagnostic efficacy of the above imaging agents in renal cancer especially clear cell renal cell carcinoma and lymphoma was evaluated
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None